Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Up 176.3% in February

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 25,700 shares, a growth of 176.3% from the January 31st total of 9,300 shares. Based on an average daily volume of 87,100 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.1% of the company’s stock are short sold.

Shuttle Pharmaceuticals Trading Down 0.7 %

Shares of SHPH stock traded down $0.00 during trading hours on Friday, reaching $0.61. 69,677 shares of the company’s stock were exchanged, compared to its average volume of 69,576. The stock’s 50 day moving average is $0.77 and its 200-day moving average is $1.13. Shuttle Pharmaceuticals has a fifty-two week low of $0.57 and a fifty-two week high of $4.71. The company has a market cap of $2.48 million, a price-to-earnings ratio of -0.15 and a beta of -1.75.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .